In HNSCC, TIM-3 exerts a pivotal role, with a substantial proportion of cases (91.3%) displaying TIM-3+ tumour-infiltrating lymphocytes (TILs), either intratumourally or in the peritumoural stroma [46]. Here, HAVCR2 is linked to neoplasm.